Conagra (CAG) Bets “GLP-1 Friendly” Labels Can Offset a Shrinking Appetite for its Food

Conagra Brands, Inc. (NYSE:CAG) has become the first major food brand to label its products as "GLP-1 friendly," with the hope that this strategy can offset a shrinking appetite for packaged food due to the increasing use of weight-loss drugs like Ozempic, Wegovy, and Mounjaro. GLP-1 drugs have led households with users to cut grocery spending by 5.5% in their first six months and consume 21% fewer calories.

Conagra's Healthy Choice frozen meals and Slim Jim are among the products bearing the new label, and the company reports faster sales for these items compared to competitors' similar claims. However, Conagra is facing significant financial challenges, including a $1.62 billion net loss, a $1.96 billion goodwill and brand impairment charge, and a 50% dividend cut.

The company is implementing operational changes to improve its business, including brand-building investments, supply chain modernization, and in-sourcing. Despite these efforts, Conagra expects organic sales to decline 1% to 3% and adjusted operating margin to fall to 10% to 10.5% in fiscal 2027. The GLP-1-friendly strategy may face competition from other major food brands such as Nestlé, Danone, General Mills, and Coca-Cola, which are also adapting to GLP-1 trends.

Investors will need to monitor whether Conagra can leverage its early move into GLP-1-friendly foods and cost savings to achieve lasting growth and higher profits.